Vectus Biosystems Limited

A$0.07As of Sun 8 Nov 2026, 12:00 UTC
ASX:VBSHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (26.05%)
Div yield —
ROE 139.32%
Biotechnology
Beta (5Y) 0.42
PE TTM 2.491
TSR TTM (50.00%)
Mkt cap A$4.353M
ROIC 58.59%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.075
7.07%
175.05%
Hold 1|9|5|11|12
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
14.16%
17.67%
21.44%
15.24%
Revenue$M
0.278
0.289
0.300
0.302
0.59%
1.17%
3.19%
5.42%
Peers (US$2.990M)
Cap (US$)
PE
3.826M
—
3.645M
—
2.990M
—
Capital
TTM
5Y
10Y
Leveragex
1.253
(0.271)
(0.221)
EBIT/Intx
1.042
0.270
0.278
Own earn%
(23.79)
(62.51)
(46.69)
Sh yield%
42.80
33.60
35.09
Owners
Insiders/Inst%
7.15
66.32
Short interest%
4.69
SBC / revenue%
2.43
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
5–8
$1 testx
—
Incr. ROIC%
4